Single platform femtosecond laser announced at ESCRS

Article

Bausch + Lomb and Technolas Perfect Vision have announced the release of the VICTUS femtosecond laser platform at this year's ESCRS meeting in Vienna, Austria.

Bausch + Lomb (B+L) and Technolas Perfect Vision (TPV) have announced the release of the VICTUS femtosecond laser platform that supports cataract, refractive and therapeutic procedures at this year’s ESCRS meeting in Vienna, Austria.

CEO and president of the Global Surgical Business for B+L, Robert E. Grant, commented on the news, stating, "Our focus is on bringing innovative products, like the VICTUS platform, to the market that uniquely benefit ophthalmic surgeons and patients. TPV's advanced German engineering and precise manufacturing are perfect complements to B+L's surgical portfolio."

The companies have announced that early clinical data on the platform will be presented at the upcoming AAO meeting in Orlando, Florida, USA and at the Asia-Pacific Association of Cataract and Refractive Surgeons in Seoul, South Korea. Additionally, both companies are currently working with regulatory authorities to secure marketing approvals and will promote the platform globally.

This news comes shortly after the recent announcement that B+L and TPV entered into a definitive agreement with an option for B+L to purchase all outstanding and not owned TPV shares.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.